Asthma

After showing the ability to regain patients' senses of smell and taste in a pair of phase 3 trials, the biologic becomes the first indicated for CRSwNP.

A team from Johns Hopkins assessed pediatric patients in Baltimore—an area with severe rates of asthma, indoor air pollution, and poor diets.

A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.

Dysfunctional breathing is a common comorbidity in patients with severe asthma, and is associated with increased patient anxiety and depression.

The signs and symptoms of the rare, chronic condition are not consistently detected in the first line of care.

Neighborhoods redlined in the 1930s continue to feel the effects of the racially discriminatory practice, including differences in asthma-related emergency visits.

Within a week of treatment on the investigative biologic, patients with severe form of the condition were reporting a return of smell and taste.

Among patients in SINUS-24 and SINUS-52 with chronic rhinosinusitis with nasal polyps and comorbid asthma, dupilumab significantly improved function and patient-reported outcomes.

In an open-label trial among adults with mild asthma, budesonide-formoterol treatment was superior to albuterol for the prevention of asthma exacerbations.

Investigators were seeking an alternative therapy for persistent asthma patients reporting insufficient benefit from mometasone, despite it being the guideline standard.

Children with asthma who used the eAsthma Tracker app weekly missed 60% fewer days of school and their parents missed 70% fewer days of work.

CompEx combines deteriorations and frequency of asthma exacerbations that are recorded twice daily by patients. An algorithm is developed based off of patient deterioration below threshold limits.

Close to half of observed patients had severe asthma and uncontrolled even with high doses of ICS or LABA. Among them, more than half had the eosinophilic inflammatory phenotype.

A new test involving pediatric lung function shows that just 15% of patients will achieve strict remission in adulthood.

Approximately one-half of patients with chronic rhinosinusitis with nasal polyposis have asthma. The less-invasive FeNO test may help detect comorbid patients.

Research has shown that few children with asthma correctly use their inhalers, despite guidelines explicitly stating that each physician visit should include review of inhaler technique and use of devices.

The GSK triple-combination FF/UMEC/VI inhaler reported significant lung function improvement in patients with inadequately controlled asthma.

The injectable IL-5 inhibitor therapy is more commonly recommended for patients with greater eosinophil counts.

A 68,000-plus patient study could lead to new therapies, more complete and efficient ways to diagnose asthma, and help identify environmental factors that protect against it.

Six-month ACT, lung function, exacerbation rate scores showed no correlation between exacerbations and the standard for patient scoring.

Pregnant women who suffer from asthma reported a two-fold greater risk for PPD according to the results of a large-scale Quebec hospital cohort.

SHBG is present in about 9.7% of adult women who have asthma, and 5.4% of adult men with asthma.

Investigators believe this is the first study to show both the omega-3 protective effect and deleterious effect of omega-6 on indoor particular matter exposure and systemic inflammation.

Randomized, placebo-controlled trial found a 50% reduction in absolute eosinophil count in 90% of patients.

As recently as 2010, anywhere from 18% to 36% of pediatric asthma cases were driven by traffic-related air pollution.